Risk Factors of External Ventricular Drain Infection: proposing a Model for Future Studies by Sorinola, Abayomi et al.
REVIEW
published: 15 March 2019
doi: 10.3389/fneur.2019.00226
Frontiers in Neurology | www.frontiersin.org 1 March 2019 | Volume 10 | Article 226
Edited by:
Mattias K. Sköld,
Uppsala University, Sweden
Reviewed by:
David W. Nelson,
Karolinska Institute (KI), Sweden
Silvia Lima Costa,
Federal University of Bahia, Brazil
*Correspondence:
Abayomi Sorinola
sorinola_abayomi@hotmail.com
Specialty section:
This article was submitted to
Neurotrauma,
a section of the journal
Frontiers in Neurology
Received: 22 September 2018
Accepted: 22 February 2019
Published: 15 March 2019
Citation:
Sorinola A, Buki A, Sandor J and
Czeiter E (2019) Risk Factors of
External Ventricular Drain Infection:
Proposing a Model for Future Studies.
Front. Neurol. 10:226.
doi: 10.3389/fneur.2019.00226
Risk Factors of External Ventricular
Drain Infection: Proposing a Model
for Future Studies
Abayomi Sorinola 1*, Andras Buki 1,2, Janos Sandor 3 and Endre Czeiter 1,2,4
1Department of Neurosurgery, Medical School, University of Pécs, Pécs, Hungary, 2 János Szentágothai Research Centre,
University of Pécs, Pécs, Hungary, 3Department of Bio-statistics and Epidemiology, Faculty of Public Health, University of
Debrecen, Debrecen, Hungary, 4MTA PTE Clinical Neuroscience MR Research Group, University of Pécs, Pécs, Hungary
Background: External ventricular drain (EVD) has a major role in the management and
monitoring of intracranial pressure (ICP) and its major complication is EVD infection. The
risk factors for EVD infection are still a major topic of controversy, hence the need for
further research.
Objective: The objective of this review was to identify risk factors that affect the
incidence of EVD infection and create a model, which can be used in future studies
in order to contribute to elaborations on guideline for EVD.
Methods: A PubMed and Google Scholar literature search was performed and data
were extracted from studies published from 1966 through 2017. The search of the
databases generated 604 articles and 28 articles of these were found to be relevant.
A manual search of the 28 relevant papers generated 4 new articles. Of the 32 relevant
articles, 20 articles that performed a multivariate analysis of the suspected risk factors of
EVD infection and had a positive culture as a mandatory component in diagnosis were
selected for data collection and analysis.
Results: Because reviewed papers investigated only a few influencing factors, and could
not determine convincingly the real risk factors of EVD infection and their real strengths.
A total of 15 supposed influencing factors which includes: age, age & sex interactions,
coinfection, catheter insertion outside the hospital, catheter type, CSF leakage, CSF
sampling frequency, diagnosis, duration of catheterization, ICP > 20 mmHg, irrigation,
multiple catheter, neurosurgical operation, reduced CSF glucose at catheter insertion
and sex were identified.
Conclusion: This review summarizes a set of variables which have to be covered
by future clinical epidemiological investigations in order to describe the etiological
background of EVD infection.
Keywords: (EVD) external ventricular drain, EVD infection, ventricular catheter (VC), ventricular catheter infection,
risk factors
INTRODUCTION
Traumatic brain injury (TBI) is a major cause of death and disability in the world harboring
significant public health and socio-economic importance. TBI is estimated to be the primary cause
of mortality and disability among young individuals. In 2013, in the United States, TBI was a
diagnosis in more than 2.5 million emergency department visits and 282,000 hospitalizations.
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According to the Center for Disease Control and Prevention
(CDC), TBI contributes to 30% of all injury-related deaths in
the United States (1). Epidemiological data on TBI from the
European Union are scarce, but do indicate an incidence of
hospitalized TBI of approximately 235/100,000/year, although
substantial variation exists between European countries (2). TBI
is associated with a cost of over $76 billion in the USA (3) and
least e33 billion in Europe (4) and severe TBI accounts for 90%
total medical cost of TBI (1).
Ventriculostomy is frequently used in the management and
monitoring of intracranial pressure (ICP) in severe TBI patients.
In the US, an average of about 20,586–25,634 (24,380) patients
per annum undergo ventriculostomy (5).
Although TBI management is our main interest and the
application of external ventricular drain (EVD) is a crucial point
in TBI protocols, EVD infections are among the complications
for EVD application with high influence on the outcome of the
underlying disease and are not well-characterized.
Many conditions such as intracranial hemorrhage,
intracranial tumor and hydrocephalus prompt the use of EVD.
EVD application is frequently complicated by misplacement,
hemorrhage, dislodgement, blockage, and most importantly
infection (6). EVD infection rate ranges from 0 to 22% (7–9)
resulting in a significant increase in cost, hospital stay, morbidity,
and mortality (6, 10).
Due to the heterogeneous knowledge on the effectiveness of
EVD, uncertainties of EVD application and the infection related
complications, further research is required. The aim of this
qualitative review was to identify risk factors that can potentially
affect the incidence of EVD infection and create a model, which
can be used in future studies to determine the real risk factors
with their real strengths in order to contribute to the elaborations
on the guideline for EVD application among TBI patients.
METHODS
We performed a systematic search on PubMed and Google
Scholar databases (from 1966 to August 2017) for relevant studies
related to ventricular drain infections. Keywords used in the
search strategy include:
1. Infections (ventricular drain, ventriculostomy related,
external ventricular drain, ventricular catheter, and
extra-ventricular drain) and
2. One of the following [traumatic brain injury, Intensive
care (ICU) patients’, neuro-intensive care (NICU)
patients, head injury, brain injury, cerebral hemorrhage,
sub-arachnoid hemorrhage].
The combination of keywords generated 328 and 276 references
on PubMed and Google Scholar, respectively. Of 604 references,
28 were found relevant after the title and abstract screening. In
addition to these, the references of these 28 relevant articles were
searched manually to find more related articles, which generated
4 new articles.
The 32 relevant articles were screened; those that performed
a multivariate analysis of suspected risk factors (making a
difference between factors which proved to be a confounding
factor in a study and factors which can have an influence on
outcome according to the published reports) and had a positive
culture as a mandatory component in diagnosis were selected for
data collection and analysis. Twenty articles (16 of these are as a
result of the keyword-based literature search and 4 are as a result
of manual reference search) were finally selected for our review.
The cumulative sample size of the 20 studies was 5,113 patients,
with a median of 164.5.
In our review, quantitative methods (meta-analysis) could not
be applied due to the heterogeneity of the studies in respect to
the risk factors identified i.e., the number of studies identifying a
certain risk factor was small, making meta-analysis impossible.
As a result of the heterogeneity of the clinical terms used
by the authors a common term was chosen for the varying
terminologies. “Age” and “younger age” were simplified to age;
“co-infection,” “concurrent systemic infection,” “open infection
source,” and “skin colonization by pathogen” were simplified
to co-infection; “Depressed Cranial Fracture repairing surgery
(DSF),” “neurosurgical operation,” “length of tunneling (> 5cm),”
“craniotomy,” and “two or more burr-holes” were simplified to
neurosurgical operation; “duration of catheterization,” “duration
of catheterization (>11 days)” and “intracranial pressure
monitoring (ICPM) > 5 days” were simplified to duration of
catheterization; “standard catheter,” “conventional catheter” and
“antibiotic coated catheter” were simplified to catheter type;
“neuro-trauma,” “multiple trauma,” “sub-arachnoid hemorrhage
(SAH),” “intraventricular hemorrhage (IVH),” “intracerebral
hemorrhage (ICH),” and “intraventricular hemorrhage (IVH)”
were simplified to diagnosis; “repeat insertion,” “patients with
>1 ICPM,” “multiple catheter replacements,” and “number of
catheters” were simplified tomultiple catheters.
Duration of catheterization refers to the time period between
post-catheter insertion and the detection of infection or discharge
from ICU in the absence of infection.
According to CDC, meningitis or ventriculitis must meet at
least one of the following criteria:
1. Patient has organism(s) identified from cerebrospinal fluid
(CSF) by a culture or non-culture based microbiologic
testing method which is performed for purposes of clinical
diagnosis or treatment for example, not Active Surveillance
Culture/Testing (ASC/AST).
2. Patient has at least two of the following:
i. fever (>38.0◦C) or headache (Note: Elements of “i” alone
may not be used to meet the two required elements)
ii. meningeal sign(s)∗
iii. cranial nerve sign(s)∗
3. Patient ≤1 year of age has at least two of the following
elements: i. fever (>38.0◦C), hypothermia, apnea∗,
bradycardia∗, or irritability∗ (Note: Elements of “i” alone may
not be used to meet the required two elements).
ii. meningeal signs∗
iii. cranial nerve signs∗
∗ With no other recognized cause
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And at least one of the following for Number 2 and two of
the following for Number 3 listed above:
a. increased white cells, elevated protein, and decreased glucose
in CSF (per reporting laboratory’s reference range)
b. organism(s) seen on Gram stain of CSF
c. organism(s) identified from blood by a culture or non-culture
based microbiologic testing method which is performed for
purposes of clinical diagnosis or treatment, for example, not
Active Surveillance Culture/Testing (ASC/AST)
d. diagnostic single antibody titer (IgM) or 4-fold increase in
paired sera (IgG) for organism
The definition of infection varied among authors. Some defined
infection as a positive CSF culture from either the ventricular
catheter or lumbar subarachnoid space, verified by growth
on agar plates (11–13). Others defined infection by the CDC
criteria for meningitis/ventriculitis (14, 15). Some authors
defined infection with a few criteria, e.g., Mayhall et al. defined
infection as; no other detectable source of central nervous system
(CNS) infection, negative cultures of CSF obtained at the time
of catheter insertion, ventricular catheterization for 24 h or
longer and a positive CSF culture from either the ventricular
catheter or lumbar subarachnoid space. Pople et al. also defined
infection by a few criteria which includes; CSF culture with
no organisms identified on initial Gram stain that subsequently
grew a positive culture on agar, or CSF culture negative, but
with Gram stain showing either gram-positive or gram-negative
organisms, or CSF leukocytosis with a white blood cell/ red
blood cell CSF count >0.02. Omar et al. defined infection as
a positive CSF culture and Gram stain and presence of other
supportive CSF laboratory findings such as pleocytosis with
microscopic examination showing presence of white blood cells
of more than 11/mm3, a decrease in the CSF glucose level and
an increase in the CSF protein level. Standard catheter refers to
catheters without hydrogel or silver or antibiotic(s) coating or
impregnation while antibiotic coated catheter refers to catheters
coated with antibiotic(s).
RESULTS
Table 1 summarizes the factors that proved to be significant or
non-significant in the univariate analyses of the studies included
in this review. Out of the 20 articles selected for analysis,
three studies reported no significant association between the risk
factors evaluated and EVD infection (6, 15, 17) after multivariate
analysis. Altogether 15 risk factors (10 patient-related and 5
catheter-related) were identified by our review. Risk factors
found by most investigations were neurosurgical operation and
duration of catheterization. In general, the reviewed studies dealt
only with a narrow set of possible risk factors. The maximum
number of risk factors identified by a study was 5 (Table 2).
Patient Factors
Age was identified by Flibotte et al. [OR & 95%CI: 1.04, 1.01–
0.081; P-value: 0.03] and Wright et al. [HR & 95%CI: 1.051,
(1.01–1.09) P-value, 0.014] as a risk factor associated with
ventricular catheter infection. Both studies measured age in years
and found a 4–5.1% increase in risk of EVD infection per annum
respectively (11, 27).
Lo et al. reported that females [OR & 95%CI: 3.4, (1.2–
9.7); P-value, 0.02] were three times as likely to be infected as
males (21).
Age & sex interaction [HR & 95%CI: 0.912, (0.85–0.98); P-
value, 0.0112] was identified as a risk factor for EVD infection
by Wright at al. They also reported that female patients were 6
times likely to have an EVD infection than male patients (23.7%
vs. 3.1%, OR: 6.4, p < 0.003) (27).
Co-infection, a risk factor with a higher incidence among
the patient factors was identified by Bota et al. [OR & 95%CI:
3.92, (0.66–7.84); P-value, 0.02], Holloway et al. [P-value, 0.001],
Kirmani et al. [P-value, 0.002], and Mounier et al. [OR & 95%CI:
11.8, (2.5–56.8); P-value, 0.002] and was found to be significantly
associated with ventricular catheter infection (7, 19, 20, 23). The
EVD infection rates of 12, 20.7, 15, & 37.5% in patients who had
a concurrent infection vs. 7, 8.6, 6 & 4.7% in patients who did not
were reported respectively (7, 19, 20, 23).
Mounier et al. reported cerebrospinal fluid (CSF) leakage at
the site of insertion [OR & 95%CI: 10, (2.4–41.2); P-value, 0.001]
as a risk factor and that among the infected patients, most of the
catheter infection was as result of the colonization at the site of
catheter insertion (23).
Diagnosis was identified by Bota et al. [(SAH: OR & 95%CI:
2.95, (0.59–5.26); P-value, 0.02), (IVH: OR & 95%CI: 2.07, (0.65–
4.87) P-value, 0.02), (neurotrauma: P-value, 0.03)], Holloway
et al. [P-value, 0.007], and Mayhall et al. [P-value, 0.027] as
a risk factor with a high prevalence among the patient factors
with significant influence on the incidence of ventricular catheter
infection (7, 19, 22).
According to Hoefnagel et al. increased frequency of CSF
sampling [OR & 95%CI: 4.12, (1.84–9.22); P-value, 0.001] is a
risk factor to EVD infection. The authors noted that CSF was
not always sampled according to the institution’s protocol that
had been set which inevitably increased the frequency of catheter
manipulation and consequently the risk of infection (12).
According to Mayhall et al. intracranial pressure (ICP) above
20 mmHg [P-value, 0.019] is a risk factor for ventricular
catheter infection but they mention also the alternate explanation
for their observation, that patients with high ICP may need
ventricular catheter for longer periods which predisposes them
to infection (22).
Neurosurgical operation was identified by Bota et al. [OR
& 95%CI: 4.74, (0.27–9.52); P-value, 0.03], Holloway et al.
[craniotomy: P-value, 0.005; DSF: P-value, 0.003], Mayhall et al.
[P-value, 0.016], Omar et al. [OR & 95%CI: 10.46, (3.38–32.32);
P-value, 0.001], and Peter et al. [P-value, 0.047] as a risk factor
(7, 10, 19, 22, 24). The reported infection rate varied between
15.2 and 82% in patients who underwent neurosurgical operation
against 3.4 and 69% in patients who did not (7, 10, 19, 22,
24). Some authors reported that patients with one or more
neurosurgical procedures were at a significantly higher risk for
infection which may be due to immunosuppression or trauma
associated with surgical procedures (20, 22).
Gozal et al. reported that there is a significant correlation
between CSF glucose levels [OR & 95% CI: 4.87, (1.26–18.75);
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TABLE 1 | Variables identified by univariate analysis having no significant association with EVD infection and factors which showed significant association with EVD
infection only in univariate analyses.
Study Significant variables identified in uni-variate analyses Non-significant variables identified in uni-variate analyses
Arabi et al. (16) Prophylactic antibiotics. APACHE II; SAPS II; Placement of EVD outside the OR; ICU–LOS; Hospital
LOS and Mortality.
Bari et al. (17) – –
Bota et al. (7) – APACHE II; LOS; ICU mortality rate and In-hospital mortality rate.
Camacho et al. (14) Hospital–LOS; ASA I and Antibiotic prophylaxis. Duration of surgery and Mortality.
Flibotte et al. (11) Hospital – LOS and NICU - LOS Admission GCS ≤ 9; In-hospital mortality and VP shunt.
Gozal et al. (18) – –
Hagel et al. (6) ICU–LOS and Hospital LOS. BMI; ASA; Accommodation and In-hospital mortality.
Hoefnagel et al. (12) – Operating time and Prophylactic antibiotic.
Holloway et al. (19) – –
Kirmani et al. (20) Intraventricular antibiotic. Steroid use.
Lo et al. (21) – Presence of trauma.
Mayhall et al. (22) – Underlying disease; Placement of EVD in ICU; Antibiotic prophylaxis; CSF
drain Disconnections; Previous ventriculostomy and Other CNS instrument.
Mounier et al. (23) – Immunodeficiency; Recent neurosurgery; Antibiotics prophylaxis during EVD
placement; Antibiotics administration during EVD drainage; EVD placement
by resident; Emergency EVD placement; EVD exchange; Drainage lock and
EVD disconnection.
Omar et al. (24) – Venue of surgery and Surgeon’s status.
Paramore et al. (13) – Location of catheterization within the hospital.
Park et al. (25) – –
Peter et al. (10) – –
Pople et al. (26) – –
Rebuck et al. (15) – Skull fracture; Presence of multiple trauma; Penetrating head injury;
Antibiotic prophylaxis and Location of catheter placement within the hospital
Wright et al. (27) – –
EVD, External Ventricular drain; LOS, length of stay; (N)ICU, (Neuro) Intensive Care Unit; GCS, Glasgow Coma Scale; ASA, American Society of Anaesthesiologists; APACHE, Acute
Physiology And Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; CSF, Cerebrospinal Fluid; CNS, Central Nervous System; ICPM, Intracranial Pressure Monitor;
OR, Operating Room; BMI, Body Mass Index.
P-value, 0.021] drawn immediately after EVD placement
associating <50% of serum glucose and subsequent risk of
infection. Gozal et al. pointed out that this should not bemistaken
for a pre-existing systemic infection since similar association was
not found in CSF pleocytosis or protein levels which would have
been expected in an on-going infection (18).
Catheter Factors
Wright et al. reported catheter type [standard catheter vs.
antibiotic coated catheter: HR & 95% CI: 0.091, (0.02–0.41); P-
value, 0.007] as a risk factor associated with ventricular catheter
infection. In the study carried out by Wright et al. two types
of catheters (standard and antibiotic coated) were used. They
reported infection rate as 23.5% for standard catheters and as
4.3% for antibiotic coated catheters. This represents a risk ratio
of 0.18 and an absolute risk reduction of 19.2% after changing
from standard catheter to antibiotic coated catheter (27).
Park et al. reported that patients that underwent catheter
insertion outside the study center had a higher risk [HR &
95%CI: 3.42, (1.46–8.02); P-value, 0.005] of infection than patient
that underwent catheter insertion in the study center and that
there was limited information on the technique of catheter
placement or specific location of the patient outside the study
center at the time of catheter insertion. On the other hand,
Park et al. also reported that the location of catheter insertion
(OR/ICU/ED) within the study center did not significantly
influence the infection rate of patient with catheters inserted in
the study center (25).
Duration of catheterization was identified by Camacho et al.
[OR & 95%CI: 1.08, (1.1–1.2); P-value, 0.036], Flibotte et al.
[OR & 95%CI: 1.2, (1.1–1.3); P-value, 0.001], Hoefnagel et al.
[OR & 95%CI: 4.12, (1.84–9.22); P-value, 0.001], Mayhall et al.
[P-value, 0.017], Omar et al. [OR & 95%CI: 3.61, (1.19–10.94);
P-value, 0.024], Paramore et al. [P-value, 0.016], Peter et al. [P-
value < 0.001], and Pople et al. [RC & 95%CI: −0.048, (−0.092
to −0.003)] as a risk factor (10–14, 22, 24, 26). The duration of
catheterization ranged from 1 to 44 days in these studies. Some
authors suggest that the longer duration of catheterization may
cause microbial infection of the catheter (13, 19, 22) while there
is another opinion that the longer duration of catheterization is a
consequence of the catheter infection rather than the cause (6).
Multiple catheters was identified Arabi et al. [OR & 95%CI:
6.34, (1.36–29.64); P-value, 0.019], Lo et al. [OR & 95%CI: 4.6,
(2.3–9.2); P-value, < 0.0001], and Peter et al. [P-value, < 0.01]
as a risk factor for EVD infection (10, 16, 21). Arabi et al. and
Peter et al. reported an infection rate of 42 and 84.5% in patients
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who received multiple catheters vs. 3 and 18.3% in patients
who did not respectively. Lo et al. also reported that infected
patients used almost twice the amount of ventricular catheters
as their uninfected counterparts (10, 16, 21). Each additional
catheter was reported to increase the risk of infection by 4-
fold or 8% by some authors (8, 21). Arabi et al. found out
that antibiotics were given more frequently with first insertion
than with repeated insertions [68 vs. 7%, P-value, 0.001] and
it may be responsible for making multiple catheters a risk
factor (16).
Mayhall et al. who identified irrigation [P-value, 0.021] as a
risk factor for EVD infection also hypothesized that infections
are likely introduced into the ventricles by retrograde movement
of microbes due the manipulation of the catheter system (22).
DISCUSSION
The keywords and references used in our review were similar to
the keywords and references in other reviews (8, 9, 28). Despite
the sparse amount of articles on this topic, we were able to
identify a total of 15 risk factors.
According to our review, distinct studies were able to
identify only few risk factors, since the published studies were
intentionally focused to a few specific causes of EVD infection
with controlling for only few confounding factors, instead of
testing a comprehensive set of causal factors representing the
hypotheses on the etiological background. On the other hand,
the sample size of reviewed studies was rather limited, preventing
the effective identification of less dominant risk factors. Further,
the terms of investigated clinical factors were highly variable,
limiting the effectiveness of comparative evaluation. Therefore,
the research on the risk factors of EVD infection is in its
initial phase. Identification of factors which can play role in
development of infective complications of EVD was the function
of the till-now-published papers. The reviewed investigations
could contribute to the building of research model to be tested
in future, and cannot be considered as reliable quantification of
the risk factors’ role.
Although, only papers withmultivariatemodels were analyzed
in this review, as shown in Table 2, none of them could cover
the majority of risk factors. Even the paper with the most
extended model could not cover half of the identified risk factors.
Consequently, the publishedmeasures of associations reflect both
the strength of the risk factors and the confounding effects of
factors that were not included in the model but were associated
with the risk factors included in the studied models. Therefore,
the relative importance of a risk factor cannot be evaluated by the
published models. The whole set of suspected risk factors need to
be included in the model which will be tested in clinical practice
in order to determine the risk factors with their strength and
clinical importance.
There were studies that found some of the identified risk
factors not significantly associated with EVD infection in their
multivariate analysis. Age, sex, CSF leakage, catheter type, and
diagnosis were identified by more studies as not significantly
associated with EVD infection (6, 7, 10, 11, 14, 15, 17, 20,
24–27) than studies that did. On the other hand, while more
studies reported some risk factors to be significantly associated
with EVD infection, a few studies did not find a similar
association between these risk factors and EVD infection after
multivariate analysis. Duration of catheterization, co-infection,
and neurosurgical operation were found by more studies to be
associated with EVD infection than a few studies that did not
(7, 10–14, 16, 19–24, 26). Catheter insertion outside the hospital,
multiple catheters, and ICP > 20 mmHg were found to be
either associated with EVD infection or not by equal number
of studies (15–17, 25–27). The varying results from the reviewed
studies are possibly due to non-standardized research procedures
(i.e., some risk factors were selectively analyzed while some risk
factors were omitted, resulting in a possible causal or coincidental
relationship or the lack thereof between EVD infection and these
risk factors). Some of the factors presented in this review for
later research may only be confounding factors without direct
influence on ventricular catheter infection occurrence (e.g., the
association between gender and drain infection; far more males
were involved in severe injuries whereas females appeared to be a
predictive factor).
This review has a few limitations. Firstly, not all the possible
research papers were collected as only the PubMed and Google
Scholar databases were used, also the research papers published
in other languages other than English language were not
included in this review. Secondly, as mentioned previously,
the meta-analysis of the risk factors could not be carried out.
Thirdly, some of the selected papers were not focused on
EVD exclusively (some included ICP monitors). Lastly, the
explanatory power of the proposed study model could not be
determined because the studies evaluated only a narrow set of
influencing factors. Consequently, the proposed study model
may include interrelated prognostic factors and it is not possible
to predict whether factors omitted from our proposed research
model (risk factors) have high impact on manifestation of
EVD infection.
Application of ICP monitoring has recently become a major
topic of discussions in the scientific community also leading
to the conduct of major randomized clinical trial (BEST-TRIP)
(29). Nevertheless, to much of our surprise, application of such
a common monitoring and therapeutic tool is based on very
limited knowledge of purported risk factors associated with
its’ utilization.
Being aware of such complications and their rate would be
of ample importance to inform the relatives, train the care
givers as well as enhance therapeutic efficacy. We hope that the
present work not only focused attention at our above-detailed
weaknesses but also highlighted those potential factors that
should be considered when EVD-related infective complications
are to be predicted.
CONCLUSION
Studies published on risk factors of EVD infection till 2017
have serious limitations and can be considered only as
preliminary investigations which yielded a set of variables
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(patients and EVD related factors) that should be covered by
future observational epidemiological investigations. Despite the
huge cumulative sample size 5,113 patients of these studies,
the comparability of the results was seriously hampered by
the non-standard assessment of investigated clinical factors.
The outcome of our review is a recommendation that former
approaches should be replaced by a design able to determine
the clinical importance of factors related to EVD infection and
able to prepare a formal quantitative meta-analysis. According
to our results, the set of the parameters in the study model
should be used at a minimum–besides other factors depending
on the tested hypothesis in the etiology of EVD infection.
These variables are: age, sex, age & sex interactions, co-
infection, catheter insertion outside the hospital, catheter type,
CSF leakage, CSF sampling frequency, diagnosis, duration of
catheterization, ICP > 20 mmHg, irrigation, multiple catheter,
neurosurgical operation, and reduced CSF glucose at insertion of
ventricular catheter.
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